MetaADEDB 2.0 @ LMMD
Vemurafenib
(GPXBXXGIAQBQNI-UHFFFAOYSA-N)
Structure
SMILES
CCCS(=O)(=O)Nc1ccc(c(c1F)C(=O)c1c[nH]c2c1cc(cn2)c1ccc(cc1)Cl)F
Type(s)
Approved
ATC code(s)
L01XE15
Molecular Formula:
C23H18ClF2N3O3S
Molecular Weight:
489.922
Log P:
6.6980
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
100.3
CAS Number(s):
918504-65-1; 1029872-54-5; 1415041-85-8
Synonym(s)
1.
Vemurafenib
2.
PLX 4032
3.
PLX4032
4.
R05185426
5.
RG-7204
6.
RG7204
7.
Zelboraf
8.
RG 7204
External Link(s)
MeSHD000077484
PubChem Compound42611257
BindingDB50396483
ChEBI63637
CHEMBLCHEMBL1229517
DrugBankDB08881
DrugCentral4185
IUPHAR/BPS Guide to PHARMACOLOGY5893
KEGGdr:D09996
Therapeutic Target DatabaseD0Y9EW
ZINC52509366
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ArthralgiaFAERS: 697
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
2FatigueFAERS: 639
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
3Disease ProgressionFAERS: 489
Canada Vigilance: 5
Canada Vigilance
US FAERS
4NauseaFAERS: 443
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
5AlopeciaFAERS: 407
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
6SunburnFAERS: 270
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7MyalgiaFAERS: 238
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8VomitingFAERS: 213
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
9PruritusFAERS: 207SIDER
US FAERS
10HeadacheFAERS: 206
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
11Squamous cell carcinomaFAERS: 170SIDER
US FAERS
12Skin PapillomaFAERS: 164
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13ErythemaFAERS: 160
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
14AstheniaFAERS: 133SIDER
US FAERS
15Weight decreasedFAERS: 114SIDER
US FAERS
16HyperkeratosisFAERS: 112
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
17PainFAERS: 104
Canada Vigilance: 1
Canada Vigilance
US FAERS
18ConstipationFAERS: 100SIDER
US FAERS
19Drug ineffectiveFAERS: 94US FAERS
20Peripheral swellingFAERS: 92
Canada Vigilance: 3
Canada Vigilance
US FAERS
21DysgeusiaFAERS: 88SIDER
US FAERS
22DehydrationFAERS: 79
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Dry skinFAERS: 79SIDER
US FAERS
24SwellingFAERS: 76
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Blood lactate dehydrogenase increasedFAERS: 75US FAERS
26Joint swellingFAERS: 74
Canada Vigilance: 1
Canada Vigilance
US FAERS
27Visual ImpairmentFAERS: 67
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Squamous cell carcinoma of skinFAERS: 66SIDER
US FAERS
29AcneFAERS: 64US FAERS
30keratoacanthomaFAERS: 60
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
31Blood creatinine increasedFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Intentional product use issueFAERS: 55US FAERS
33ChillsFAERS: 52
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
34PneumoniaFAERS: 52US FAERS
35Rash erythematousFAERS: 52US FAERS
36Poor quality sleepFAERS: 50US FAERS
37Impaired work abilityFAERS: 46US FAERS
38General physical health deteriorationFAERS: 45US FAERS
39MalaiseFAERS: 42US FAERS
40UveitisFAERS: 42SIDER
US FAERS
41No adverse eventFAERS: 41US FAERS
42Skin toxicityFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
43DizzinessFAERS: 36
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
44HepatotoxicityFAERS: 36SIDER
US FAERS
45Burning sensationFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Abdominal PainFAERS: 34US FAERS
47Chest PainFAERS: 34US FAERS
48NeutropeniaFAERS: 34US FAERS
49UrticariaFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
50Back PainFAERS: 32SIDER
US FAERS
51Chest discomfortFAERS: 31US FAERS
52Skin reactionFAERS: 31US FAERS
53Atrial FibrillationFAERS: 29SIDER
US FAERS
54Malignant neoplasm progressionFAERS: 29US FAERS
55Dermatitis acneiformFAERS: 28US FAERS
56Oropharyngeal painFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
57Skin lesionFAERS: 27US FAERS
58White blood cell count decreasedFAERS: 27US FAERS
59Acute kidney injuryFAERS: 26US FAERS
60SepsisFAERS: 26US FAERS
61DermatitisFAERS: 25SIDER
US FAERS
62HypersensitivityFAERS: 25
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
63Myocardial InfarctionFAERS: 25US FAERS
64PericarditisFAERS: 25US FAERS
65Skin UlcerFAERS: 24US FAERS
66StomatitisFAERS: 24US FAERS
67Aspartate Aminotransferase IncreasedFAERS: 23US FAERS
68Keratosis pilarisFAERS: 23SIDER
US FAERS
69LeukopeniaFAERS: 23US FAERS
70Stevens-Johnson SyndromeFAERS: 2225811541CTD
SIDER
US FAERS
71FlushingFAERS: 21US FAERS
72MetastasisFAERS: 21US FAERS
73PancreatitisFAERS: 21US FAERS
74PanniculitisFAERS: 21US FAERS
75SomnolenceFAERS: 21US FAERS
76Alanine Aminotransferase IncreasedFAERS: 20US FAERS
77Febrile NeutropeniaFAERS: 20US FAERS
78HypotensionFAERS: 20SIDER
US FAERS
79EosinophiliaFAERS: 19SIDER
US FAERS
80InfectionFAERS: 19
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
81Malignant melanoma in situFAERS: 19US FAERS
82Pericardial effusionFAERS: 19US FAERS
83ThrombocytopeniaFAERS: 19US FAERS
84Eye painFAERS: 18US FAERS
85Musculoskeletal PainFAERS: 18SIDER
US FAERS
86Pulmonary EmbolismFAERS: 18US FAERS
87Radiation skin injuryFAERS: 18US FAERS
88CholestasisFAERS: 17US FAERS
89Urinary tract infectionFAERS: 17US FAERS
90Basal cell carcinomaFAERS: 16SIDER
US FAERS
91EpilepsyFAERS: 16US FAERS
92Gamma-Glutamyltransferase IncreasedFAERS: 16SIDER
US FAERS
93PalpitationsFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Toxicity to various agentsFAERS: 16US FAERS
95Abdominal discomfortFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Actinic keratosisFAERS: 15SIDER
US FAERS
97AgeusiaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
98AmnesiaFAERS: 15US FAERS
99AngioedemaFAERS: 15US FAERS
100Cerebrovascular accidentFAERS: 15US FAERS
101Lymphocyte count decreasedFAERS: 15US FAERS
102TachycardiaFAERS: 15US FAERS
103Thermal burnFAERS: 15US FAERS
104Toxic Epidermal NecrolysisFAERS: 15SIDER
US FAERS
105furuncleFAERS: 15US FAERS
106AscitesFAERS: 14US FAERS
107Blood alkaline phosphatase increasedFAERS: 14US FAERS
108Bone painFAERS: 14US FAERS
109Erythema MultiformeFAERS: 14SIDER
US FAERS
110Limb massFAERS: 14US FAERS
111Respiratory FailureFAERS: 14US FAERS
112jaundiceFAERS: 14US FAERS
113CellulitisFAERS: 13US FAERS
114ConjunctivitisFAERS: 13US FAERS
115Disseminated Intravascular CoagulationFAERS: 13US FAERS
116Neutrophil count abnormalFAERS: 13US FAERS
117Neutrophilic panniculitisFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Transaminases increasedFAERS: 13US FAERS
119TremorFAERS: 13US FAERS
120Unevaluable eventFAERS: 13US FAERS
121AnxietyFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Atrial FlutterFAERS: 12US FAERS
123BlindnessFAERS: 12US FAERS
124DysphoniaFAERS: 12US FAERS
125Eye irritationFAERS: 12US FAERS
126LymphadenopathyFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
127PhotophobiaFAERS: 12US FAERS
128ArthritisFAERS: 11SIDER
US FAERS
129CystFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
130DeafnessFAERS: 11US FAERS
131DiplopiaFAERS: 11US FAERS
132InflammationFAERS: 11US FAERS
133LymphopeniaFAERS: 11US FAERS
134Neutrophil count decreasedFAERS: 11US FAERS
135SarcoidosisFAERS: 11US FAERS
136nervous system disorderFAERS: 11SIDER
US FAERS
137ChromaturiaFAERS: 10US FAERS
138FlatulenceFAERS: 10US FAERS
139Oral candidiasisFAERS: 10US FAERS
140PapillomaFAERS: 10US FAERS
141PneumonitisFAERS: 10US FAERS
142AbasiaFAERS: 9US FAERS
143AcanthosisFAERS: 9US FAERS
144Drug administration errorFAERS: 9US FAERS
145Ejection Fraction DecreasedFAERS: 9US FAERS
146Feeling abnormalFAERS: 9US FAERS
147HepatitisFAERS: 9US FAERS
148Melanomatous meningitisFAERS: 9US FAERS
149Memory impairmentFAERS: 9US FAERS
150Rash follicularFAERS: 9US FAERS
151ScabFAERS: 9US FAERS
152Tumour haemorrhageFAERS: 9US FAERS
153Drug resistanceFAERS: 8US FAERS
154DyspepsiaFAERS: 8US FAERS
155GastritisFAERS: 8US FAERS
156HypophagiaFAERS: 8US FAERS
157IridocyclitisFAERS: 8US FAERS
158Lipase increasedFAERS: 8US FAERS
159Otitis ExternaFAERS: 8US FAERS
160Pain of skinFAERS: 8US FAERS
161PapuleFAERS: 8US FAERS
162ProteinuriaFAERS: 8US FAERS
163Recall phenomenonFAERS: 8US FAERS
164Wrong technique in product usage processFAERS: 8US FAERS
165Blood cholesterol increasedFAERS: 7US FAERS
166Blood potassium decreasedFAERS: 7US FAERS
167CholecystitisFAERS: 7US FAERS
168Depressed Level of ConsciousnessFAERS: 7US FAERS
169Drug dose omissionFAERS: 7US FAERS
170Electrocardiogram abnormalFAERS: 7US FAERS
171Electrolyte imbalanceFAERS: 7US FAERS
172Erythema NodosumFAERS: 7SIDER
US FAERS
173InfluenzaFAERS: 7US FAERS
174Intestinal PerforationFAERS: 7US FAERS
175LeukocytosisFAERS: 7US FAERS
176Lip swellingFAERS: 7US FAERS
177Metastatic NeoplasmFAERS: 7US FAERS
178Musculoskeletal stiffnessFAERS: 7US FAERS
179Pulmonary thrombosisFAERS: 7US FAERS
180Sinus TachycardiaFAERS: 7US FAERS
181Solar dermatitisFAERS: 7US FAERS
182ThrombosisFAERS: 7US FAERS
183TinnitusFAERS: 7US FAERS
184VasculitisFAERS: 7SIDER
US FAERS
185Angina PectorisFAERS: 6US FAERS
186AsthenopiaFAERS: 6US FAERS
187BronchitisFAERS: 6US FAERS
188Cardiac ArrestFAERS: 6US FAERS
189Cardiac TamponadeFAERS: 6US FAERS
190CardiotoxicityFAERS: 6US FAERS
191Deep Vein ThrombosisFAERS: 6US FAERS
192ErysipelasFAERS: 6US FAERS
193Facial paralysisFAERS: 6US FAERS
194Intestinal ObstructionFAERS: 6US FAERS
195Mental status changesFAERS: 6US FAERS
196Neck PainFAERS: 6US FAERS
197Night sweatsFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
198Nipple painFAERS: 6US FAERS
199PancytopeniaFAERS: 6US FAERS
200Skin hypertrophyFAERS: 6US FAERS
201UlcerFAERS: 6US FAERS
202VertigoFAERS: 6US FAERS
203XerosisFAERS: 6US FAERS
204Activities of daily living impairedFAERS: 5US FAERS
205BronchopneumoniaFAERS: 5US FAERS
206ColitisFAERS: 5US FAERS
207Duodenal UlcerFAERS: 5US FAERS
208Exfoliative rashFAERS: 5US FAERS
209FolliculitisFAERS: 5SIDER
US FAERS
210HemiparesisFAERS: 5US FAERS
211HordeolumFAERS: 5US FAERS
212HyperpyrexiaFAERS: 5US FAERS
213Intercepted medication errorFAERS: 5US FAERS
214Joint stiffnessFAERS: 5US FAERS
215LethargyFAERS: 5US FAERS
216Medication ErrorFAERS: 5US FAERS
217MelanosisFAERS: 5US FAERS
218NasopharyngitisFAERS: 5US FAERS
219NystagmusFAERS: 5US FAERS
220Product quality issueFAERS: 5US FAERS
221Pulmonary toxicityFAERS: 5US FAERS
222Retinal DetachmentFAERS: 5US FAERS
223RhabdomyolysisFAERS: 5US FAERS
224Septic ShockFAERS: 5US FAERS
225SynovitisFAERS: 5US FAERS
226Tongue blisteringFAERS: 5US FAERS
227AcantholysisFAERS: 4US FAERS
228AphasiaFAERS: 4US FAERS
229AphoniaFAERS: 4US FAERS
230Benign neoplasm of skinFAERS: 4US FAERS
231Blood bilirubin abnormalFAERS: 4US FAERS
232Blood bilirubin decreasedFAERS: 4US FAERS
233Blood creatine phosphokinase increasedFAERS: 4US FAERS
234Blood creatinine abnormalFAERS: 4US FAERS
235Blood glucose increasedFAERS: 4US FAERS
236BronchospasmFAERS: 4US FAERS
237Colon adenomaFAERS: 4US FAERS
238CryingFAERS: 4US FAERS
239CystitisFAERS: 4US FAERS
240DeliriumFAERS: 4US FAERS
241DisorientationFAERS: 4US FAERS
242DysarthriaFAERS: 4US FAERS
243Eccrine squamous syringometaplasiaFAERS: 4US FAERS
244Electrocardiogram changeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
245Gastrointestinal toxicityFAERS: 4US FAERS
246Guillain-Barre SyndromeFAERS: 4US FAERS
247HypersomniaFAERS: 4US FAERS
248Impaired self-careFAERS: 4US FAERS
249Incorrect dose administeredFAERS: 4US FAERS
250Intentional product misuseFAERS: 4US FAERS
251Iron deficiencyFAERS: 4US FAERS
252MaculeFAERS: 4US FAERS
253Melanoma recurrentFAERS: 4US FAERS
254Neutrophilic dermatosisFAERS: 4US FAERS
255NoduleFAERS: 4US FAERS
256PurpuraFAERS: 4US FAERS
257Radiation injuryFAERS: 4US FAERS
258Radiation necrosisFAERS: 4US FAERS
259Retinal Vein OcclusionFAERS: 4SIDER
US FAERS
260Skin neoplasm excisionFAERS: 4US FAERS
261SyncopeFAERS: 4US FAERS
262Therapy non-responderFAERS: 4US FAERS
263VIIth nerve paralysisFAERS: 4SIDER
US FAERS
264Wound InfectionFAERS: 4US FAERS
265AbscessFAERS: 3US FAERS
266AcanthomaFAERS: 3US FAERS
267Acute myocardial infarctionFAERS: 3US FAERS
268AgitationFAERS: 3US FAERS
269Anal abscessFAERS: 3US FAERS
270Blood alkaline phosphatase abnormalFAERS: 3US FAERS
271Blood glucose decreasedFAERS: 3US FAERS
272Blood immunoglobulin G decreasedFAERS: 3US FAERS
273Blood potassium increasedFAERS: 3US FAERS
274Blood urea increasedFAERS: 3US FAERS
275Central nervous system lesionFAERS: 3US FAERS
276ChokingFAERS: 3US FAERS
277Clostridium difficile infectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
278CyanosisFAERS: 3US FAERS
279DisabilityFAERS: 3US FAERS
280Diverticular perforationFAERS: 3US FAERS
281DysuriaFAERS: 3US FAERS
282Ear discomfortFAERS: 3US FAERS
283EczemaFAERS: 3US FAERS
284Emotional disorderFAERS: 3US FAERS
285Enterocolitis bacterialFAERS: 3US FAERS
286EructationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
287Extremity necrosisFAERS: 3US FAERS
288Eye inflammationFAERS: 3US FAERS
289Facial ParesisFAERS: 3US FAERS
290Gaze palsyFAERS: 3US FAERS
291Head discomfortFAERS: 3US FAERS
292HypercreatinaemiaFAERS: 3US FAERS
293Hypertensive cardiomyopathyFAERS: 3US FAERS
294HypertransaminasaemiaFAERS: 3US FAERS
295HypothyroidismFAERS: 3US FAERS
296HypoxiaFAERS: 3US FAERS
297IncontinenceFAERS: 3US FAERS
298IritisFAERS: 3US FAERS
299Large intestine perforationFAERS: 3US FAERS
300Lower respiratory tract infectionFAERS: 3US FAERS
301MalnutritionFAERS: 3SIDER
US FAERS
302Mental impairmentFAERS: 3US FAERS
303Musculoskeletal chest painFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
304Mycosis FungoidesFAERS: 3US FAERS
305NocturiaFAERS: 3US FAERS
306Ocular discomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
307Optic NeuritisFAERS: 3US FAERS
308ParesisFAERS: 3US FAERS
309Performance status decreasedFAERS: 3US FAERS
310PiloerectionFAERS: 3US FAERS
311Pregnancy of partnerFAERS: 3US FAERS
312PresyncopeFAERS: 3US FAERS
313Product use issueFAERS: 3US FAERS
314Radiosensitisation therapyFAERS: 3US FAERS
315Septal panniculitisFAERS: 3US FAERS
316SinusitisFAERS: 3US FAERS
317Systemic Inflammatory Response SyndromeFAERS: 3US FAERS
318Therapy cessationFAERS: 3US FAERS
319Therapy changeFAERS: 3US FAERS
320Throat irritationFAERS: 3US FAERS
321VitiligoFAERS: 3US FAERS
322Wrong technique in drug usage processFAERS: 3US FAERS
323treatment failureFAERS: 3US FAERS
324Accidental overdoseFAERS: 2US FAERS
325AphagiaFAERS: 2US FAERS
326AppendicitisFAERS: 2US FAERS
327ArthropathyFAERS: 2US FAERS
328AsphyxiaFAERS: 2US FAERS
329Back disorderFAERS: 2US FAERS
330Blood count abnormalFAERS: 2US FAERS
331Blood potassium abnormalFAERS: 2US FAERS
332Blood sodium decreasedFAERS: 2US FAERS
333CachexiaFAERS: 2US FAERS
334Candida sepsisFAERS: 2US FAERS
335CandidiasisFAERS: 2US FAERS
336CataractFAERS: 2US FAERS
337Cell DeathFAERS: 2US FAERS
338Central nervous system melanomaFAERS: 2US FAERS
339CheilitisFAERS: 2US FAERS
340CholangitisFAERS: 2US FAERS
341CholelithiasisFAERS: 2US FAERS
342Cutaneous sarcoidosisFAERS: 2US FAERS
343DementiaFAERS: 2US FAERS
344Diabetes MellitusFAERS: 2US FAERS
345Diet refusalFAERS: 2US FAERS
346Disease recurrenceFAERS: 2US FAERS
347Drug dispensing errorFAERS: 2US FAERS
348Drug effect incompleteFAERS: 2US FAERS
349Drug level increasedFAERS: 2US FAERS
350Drug physiologic incompatibilityFAERS: 2US FAERS
351DuodenitisFAERS: 2US FAERS
352Echocardiogram abnormalFAERS: 2US FAERS
353EncephalitisFAERS: 2US FAERS
354EnteritisFAERS: 2US FAERS
355EpistaxisFAERS: 2US FAERS
356Expired product administeredFAERS: 2US FAERS
357Feeling ColdFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
358FrostbiteFAERS: 2US FAERS
359Gastric ulcerFAERS: 2US FAERS
360General physical condition abnormalFAERS: 2US FAERS
361Genital HerpesFAERS: 2US FAERS
362GlaucomaFAERS: 2US FAERS
363HepatomegalyFAERS: 2US FAERS
364HidradenitisFAERS: 2US FAERS
365HydropneumothoraxFAERS: 2US FAERS
366Hyperkeratosis lenticularis perstansFAERS: 2US FAERS
367HyperthyroidismFAERS: 2US FAERS
368HypogeusiaFAERS: 2US FAERS
369ImmunosuppressionFAERS: 2US FAERS
370IndurationFAERS: 2US FAERS
371Infected neoplasmFAERS: 2US FAERS
372Intestinal infarctionFAERS: 2US FAERS
373IntussusceptionFAERS: 2US FAERS
374Joint Range of Motion DecreasedFAERS: 2US FAERS
375Leukocytoclastic vasculitisFAERS: 2US FAERS
376Macular degenerationFAERS: 2US FAERS
377Malignant melanoma stage IVFAERS: 2US FAERS
378Middle insomniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
379NephrolithiasisFAERS: 2US FAERS
380NeuralgiaFAERS: 2US FAERS
381Oncologic complicationFAERS: 2US FAERS
382Oral fungal infectionFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
383Oral mucosal eruptionFAERS: 2US FAERS
384OsteosclerosisFAERS: 2US FAERS
385OverdoseFAERS: 2US FAERS
386PCO2 decreasedFAERS: 2US FAERS
387Palmar erythemaFAERS: 2SIDER
US FAERS
388Palpable purpuraFAERS: 2US FAERS
389Pelvic venous thrombosisFAERS: 2US FAERS
390PeriodontitisFAERS: 2US FAERS
391Periorbital contusionFAERS: 2US FAERS
392PeritonitisFAERS: 2US FAERS
393Personality ChangeFAERS: 2US FAERS
394Physical disabilityFAERS: 2US FAERS
395Poor quality drug administeredFAERS: 2US FAERS
396Precancerous cells presentFAERS: 2US FAERS
397PregnancyFAERS: 2US FAERS
398Prerenal failureFAERS: 2US FAERS
399Product dose omissionFAERS: 2US FAERS
400PseudolymphomaFAERS: 2US FAERS
401Pulmonary HypertensionFAERS: 2US FAERS
402Renal painFAERS: 2US FAERS
403Respiratory distressFAERS: 2US FAERS
404Restless Legs SyndromeFAERS: 2US FAERS
405RetchingFAERS: 2US FAERS
406Rheumatic FeverFAERS: 2US FAERS
407Rheumatoid ArthritisFAERS: 2US FAERS
408Skin irritationFAERS: 2US FAERS
409Squamous cell carcinoma of lungFAERS: 2US FAERS
410Stasis dermatitisFAERS: 2US FAERS
411Subcutaneous AbscessFAERS: 2US FAERS
412Suicide attemptFAERS: 2US FAERS
413Superficial spreading melanoma stage IFAERS: 2US FAERS
414Temperature intoleranceFAERS: 2US FAERS
415Tension HeadacheFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
416Terminal stateFAERS: 2US FAERS
417Tooth LossFAERS: 2US FAERS
418Treatment related secondary malignancyFAERS: 2US FAERS
419Urinary IncontinenceFAERS: 2US FAERS
420Vascular Access ComplicationFAERS: 2US FAERS
421Vitamin D DeficiencyFAERS: 2US FAERS
422Vitreous floatersFAERS: 2US FAERS
423Wound dehiscenceFAERS: 2US FAERS
424XerodermaFAERS: 2US FAERS
425cancer surgeryFAERS: 2US FAERS
426ATRIAL ENLARGEMENTFAERS: 1US FAERS
427Abdominal massFAERS: 1US FAERS
428AcidosisFAERS: 1US FAERS
429Acute Coronary SyndromeFAERS: 1US FAERS
430Acute prerenal failureFAERS: 1US FAERS
431Acute psychosisFAERS: 1US FAERS
432Adverse eventFAERS: 1US FAERS
433AgranulocytosisFAERS: 1US FAERS
434AllodyniaFAERS: 1US FAERS
435Alopecia AreataFAERS: 1US FAERS
436AlveolitisFAERS: 1US FAERS
437AmputationFAERS: 1US FAERS
438Amylase increasedFAERS: 1US FAERS
439AmyloidosisFAERS: 1US FAERS
440Anaphylactic shockFAERS: 1SIDER
US FAERS
441AneurysmFAERS: 1US FAERS
442Angular cheilitisFAERS: 1US FAERS
443AnosmiaFAERS: 1US FAERS
444ApathyFAERS: 1US FAERS
445AsthmaFAERS: 1US FAERS
446Atypical pneumoniaFAERS: 1US FAERS
447Autoimmune hepatitisFAERS: 1US FAERS
448Autoimmune thyroiditisFAERS: 1US FAERS
449Bilirubin conjugated increasedFAERS: 1US FAERS
450Blood blisterFAERS: 1US FAERS
451Blood creatine increasedFAERS: 1US FAERS
452Blood creatinine decreasedFAERS: 1US FAERS
453Blood immunoglobulin A increasedFAERS: 1US FAERS
454Blood lactate dehydrogenase decreasedFAERS: 1US FAERS
455Blood pH decreasedFAERS: 1US FAERS
456Blood pressure fluctuationFAERS: 1US FAERS
457Blood testosterone decreasedFAERS: 1US FAERS
458Blood triglycerides increasedFAERS: 1US FAERS
459Blood urine presentFAERS: 1US FAERS
460Bone lesionFAERS: 1US FAERS
461Bowen's DiseaseFAERS: 1US FAERS
462Brain AbscessFAERS: 1US FAERS
463Brain DeathFAERS: 1US FAERS
464Breast tendernessFAERS: 1US FAERS
465BursitisFAERS: 1US FAERS
466C-reactive protein abnormalFAERS: 1US FAERS
467CD4 Lymphocytes DecreasedFAERS: 1US FAERS
468Carcinoma in SituFAERS: 1US FAERS
469Cardiac FlutterFAERS: 1US FAERS
470CardiomegalyFAERS: 1US FAERS
471Carpal Tunnel SyndromeFAERS: 1US FAERS
472Cerebral disorderFAERS: 1US FAERS
473Cholestatic liver injuryFAERS: 1US FAERS
474ChoroiditisFAERS: 1US FAERS
475Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
476Completed SuicideFAERS: 1US FAERS
477Compression fractureFAERS: 1US FAERS
478CraniotomyFAERS: 1US FAERS
479Cytolytic hepatitisFAERS: 1US FAERS
480DemyelinationFAERS: 1US FAERS
481Depressed moodFAERS: 1US FAERS
482Depression suicidalFAERS: 1US FAERS
483Dermatitis HerpetiformisFAERS: 1US FAERS
484Device occlusionFAERS: 1US FAERS
485Diabetic KetoacidosisFAERS: 1US FAERS
486Diabetic ulcerFAERS: 1US FAERS
487Diffuse alopeciaFAERS: 1US FAERS
488Diffuse vasculitisFAERS: 1US FAERS
489DiscomfortFAERS: 1US FAERS
490Dry gangreneFAERS: 1US FAERS
491DysbacteriosisFAERS: 1US FAERS
492DysgraphiaFAERS: 1US FAERS
493Early satietyFAERS: 1US FAERS
494EmbolismFAERS: 1US FAERS
495EnterocolitisFAERS: 1US FAERS
496EnthesopathyFAERS: 1US FAERS
497EnuresisFAERS: 1US FAERS
498EpidermolysisFAERS: 1US FAERS
499Erythrodermic psoriasisFAERS: 1US FAERS
500ErythrosisFAERS: 1US FAERS
501ExophthalmosFAERS: 1US FAERS
502Expired drug administeredFAERS: 1US FAERS
503Extra dose administeredFAERS: 1US FAERS
504Extraocular Muscle ParesisFAERS: 1US FAERS
505Eye InfectionFAERS: 1US FAERS
506Eye allergyFAERS: 1US FAERS
507Eyelid margin crustingFAERS: 1US FAERS
508Eyelid painFAERS: 1US FAERS
509Eyelid rashFAERS: 1US FAERS
510Failure to ThriveFAERS: 1US FAERS
511Fat necrosisFAERS: 1US FAERS
512Febrile bone marrow aplasiaFAERS: 1US FAERS
513Fibrin D dimer increasedFAERS: 1US FAERS
514Food PoisoningFAERS: 1US FAERS
515FormicationFAERS: 1US FAERS
516Full blood count decreasedFAERS: 1US FAERS
517Fungal pharyngitisFAERS: 1US FAERS
518GangreneFAERS: 1US FAERS
519GastroenteritisFAERS: 1US FAERS
520Gastrointestinal carcinomaFAERS: 1US FAERS
521Gastrointestinal infectionFAERS: 1US FAERS
522Gastrointestinal motility disorderFAERS: 1US FAERS
523Gastrointestinal obstructionFAERS: 1US FAERS
524Gastrointestinal perforationFAERS: 1US FAERS
525Gastrointestinal tract adenomaFAERS: 1US FAERS
526Genital erythemaFAERS: 1US FAERS
527Genital rashFAERS: 1US FAERS
528Gingival HyperplasiaFAERS: 1US FAERS
529Gingival HypertrophyFAERS: 1US FAERS
530Gingival RecessionFAERS: 1US FAERS
531GingivitisFAERS: 1US FAERS
532GlomerulonephritisFAERS: 1US FAERS
533Grip strength decreasedFAERS: 1US FAERS
534Head deformityFAERS: 1US FAERS
535HemiplegiaFAERS: 1US FAERS
536Hepatic EncephalopathyFAERS: 1US FAERS
537Hepatic Vein ThrombosisFAERS: 1US FAERS
538Hip surgeryFAERS: 1US FAERS
539Histiocytosis haematophagicFAERS: 1US FAERS
540Hormone level abnormalFAERS: 1US FAERS
541Hospice CareFAERS: 1US FAERS
542HydrocephalusFAERS: 1US FAERS
543HydronephrosisFAERS: 1US FAERS
544HydrothoraxFAERS: 1US FAERS
545HyperlipasaemiaFAERS: 1US FAERS
546HyperplasiaFAERS: 1US FAERS
547HyperventilationFAERS: 1US FAERS
548HypohidrosisFAERS: 1US FAERS
549Inadequate analgesiaFAERS: 1US FAERS
550Inappropriate schedule of drug administrationFAERS: 1US FAERS
551Incarcerated inguinal herniaFAERS: 1US FAERS
552Incorrect drug dosage form administeredFAERS: 1US FAERS
553Incorrect product storageFAERS: 1US FAERS
554Infected lymphoceleFAERS: 1US FAERS
555Infectious peritonitisFAERS: 1US FAERS
556Intestinal metastasisFAERS: 1US FAERS
557Invasive Ductal Breast CarcinomaFAERS: 1US FAERS
558KoilonychiaFAERS: 1US FAERS
559LacerationFAERS: 1US FAERS
560Lack of satietyFAERS: 1US FAERS
561Limb discomfortFAERS: 1US FAERS
562Lip exfoliationFAERS: 1US FAERS
563Lipase abnormalFAERS: 1US FAERS
564Long QT SyndromeFAERS: 1US FAERS
565Loose toothFAERS: 1US FAERS
566Loss of personal independence in daily activitiesFAERS: 1US FAERS
567Low birth weight babyFAERS: 1US FAERS
568Lung AbscessFAERS: 1US FAERS
569Lymph Node TuberculosisFAERS: 1US FAERS
570LymphomaFAERS: 1US FAERS
571MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
572MalabsorptionFAERS: 1US FAERS
573Malignant ascitesFAERS: 1US FAERS
574Malignant dysphagiaFAERS: 1US FAERS
575Malignant melanoma of sites other than skinFAERS: 1US FAERS
576Malignant neoplasm of conjunctivaFAERS: 1US FAERS
577Malignant tumour excisionFAERS: 1US FAERS
578Maternal exposure during pregnancyFAERS: 1US FAERS
579Maternal exposure timing unspecifiedFAERS: 1US FAERS
580Medication residueFAERS: 1US FAERS
581Meningeal disorderFAERS: 1US FAERS
582MeningitisFAERS: 1US FAERS
583MeningorrhagiaFAERS: 1US FAERS
584Metabolic acidosisFAERS: 1US FAERS
585Metastases to pelvisFAERS: 1US FAERS
586MiliariaFAERS: 1US FAERS
587Mole excisionFAERS: 1US FAERS
588Monocyte count increasedFAERS: 1US FAERS
589MonoparesisFAERS: 1US FAERS
590Mood swingsFAERS: 1US FAERS
591Mouth swellingFAERS: 1US FAERS
592Mucoepidermoid CarcinomaFAERS: 1US FAERS
593Muscle FatigueFAERS: 1US FAERS
594Muscle enzyme increasedFAERS: 1US FAERS
595Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
596MyocarditisFAERS: 1US FAERS
597MyopathyFAERS: 1US FAERS
598NecrosisFAERS: 1US FAERS
599Nephrotic SyndromeFAERS: 1US FAERS
600NeuritisFAERS: 1US FAERS
601NeurodermatitisFAERS: 1US FAERS
602Neutropenic sepsisFAERS: 1US FAERS
603Noninfectious myelitisFAERS: 1US FAERS
604Ocular ToxicityFAERS: 1US FAERS
605Ocular icterusFAERS: 1US FAERS
606Oral mucosal erythemaFAERS: 1US FAERS
607Oral painFAERS: 1US FAERS
608OrchitisFAERS: 1US FAERS
609OsteolysisFAERS: 1US FAERS
610OsteoporosisFAERS: 1US FAERS
611Otitis MediaFAERS: 1US FAERS
612Pancreatic carcinomaFAERS: 1US FAERS
613Pancreatic toxicityFAERS: 1US FAERS
614ParanoiaFAERS: 1US FAERS
615ParaparesisFAERS: 1US FAERS
616ParaplegiaFAERS: 1US FAERS
617Penile swellingFAERS: 1US FAERS
618Periorbital disorderFAERS: 1US FAERS
619Peripheral paralysisFAERS: 1US FAERS
620PetechiaeFAERS: 1US FAERS
621PharyngitisFAERS: 1US FAERS
622PhotodermatosisFAERS: 1US FAERS
623Pneumocystis jiroveci pneumoniaFAERS: 1US FAERS
624PneumothoraxFAERS: 1US FAERS
625PolyarthritisFAERS: 1US FAERS
626Polyneuropathy chronicFAERS: 1US FAERS
627PolyuriaFAERS: 1US FAERS
628Portal HypertensionFAERS: 1US FAERS
629Post inflammatory pigmentation changeFAERS: 1US FAERS
630Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
631Precancerous skin lesionFAERS: 1US FAERS
632Product administered to patient of inappropriate ageFAERS: 1US FAERS
633Product administration errorFAERS: 1US FAERS
634Product coating issueFAERS: 1US FAERS
635Product storage errorFAERS: 1US FAERS
636Productive CoughFAERS: 1US FAERS
637PyelonephritisFAERS: 1US FAERS
638Pyogenic granulomaFAERS: 1US FAERS
639Quality of life decreasedFAERS: 1US FAERS
640Radiation PneumonitisFAERS: 1US FAERS
641Radiation proctitisFAERS: 1US FAERS
642Radicular painFAERS: 1US FAERS
643Radiotherapy to brainFAERS: 1US FAERS
644Rectal abscessFAERS: 1US FAERS
645RegurgitationFAERS: 1US FAERS
646Relapsing FeverFAERS: 1US FAERS
647Renal Cell CarcinomaFAERS: 1US FAERS
648Renal ColicFAERS: 1US FAERS
649Renal tubular necrosisFAERS: 1US FAERS
650Retinal Artery OcclusionFAERS: 1US FAERS
651Retinal Vascular DisorderFAERS: 1US FAERS
652Retinal VasculitisFAERS: 1US FAERS
653RetinitisFAERS: 1US FAERS
654SarcopeniaFAERS: 1US FAERS
655SciaticaFAERS: 1US FAERS
656ScleritisFAERS: 1US FAERS
657SclerodermaFAERS: 1US FAERS
658Scrotal erythemaFAERS: 1US FAERS
659Sebaceous hyperplasiaFAERS: 1US FAERS
660ShockFAERS: 1US FAERS
661Sick Sinus SyndromeFAERS: 1US FAERS
662Sinus headacheFAERS: 1US FAERS
663Skin AngiosarcomaFAERS: 1US FAERS
664Skin IndurationFAERS: 1US FAERS
665Solar lentigoFAERS: 1US FAERS
666Splenic InfarctionFAERS: 1US FAERS
667Splenic RuptureFAERS: 1US FAERS
668StarvationFAERS: 1US FAERS
669Status EpilepticusFAERS: 1US FAERS
670StressFAERS: 1US FAERS
671Sudden deathFAERS: 1US FAERS
672Supraventricular tachyarrhythmiaFAERS: 1US FAERS
673Suture ruptureFAERS: 1US FAERS
674TachyarrhythmiaFAERS: 1US FAERS
675Therapeutic procedureFAERS: 1US FAERS
676Therapeutic product ineffectiveFAERS: 1US FAERS
677Therapy regimen changedFAERS: 1US FAERS
678Therapy responderFAERS: 1US FAERS
679Thrombocytopenic purpuraFAERS: 1US FAERS
680ThrombocytosisFAERS: 1US FAERS
681ThyroiditisFAERS: 1US FAERS
682TonsillitisFAERS: 1US FAERS
683Tooth InfectionFAERS: 1US FAERS
684Total bile acids increasedFAERS: 1US FAERS
685TrichorrhexisFAERS: 1US FAERS
686Unevaluable therapyFAERS: 1US FAERS
687Unresponsive to stimuliFAERS: 1US FAERS
688Urinary RetentionFAERS: 1US FAERS
689VasospasmFAERS: 1US FAERS
690Venous occlusionFAERS: 1US FAERS
691Venous thrombosis limbFAERS: 1US FAERS
692Ventricular enlargementFAERS: 1US FAERS
693Vitreous DetachmentFAERS: 1US FAERS
694VitritisFAERS: 1US FAERS
695Vulvovaginal wartsFAERS: 1US FAERS
696Wound decompositionFAERS: 1US FAERS
697XerophthalmiaFAERS: 1US FAERS
698Common wartSIDER
699Dermatitis, Phototoxic24154489CTD
700InfestationSIDER
701KeratosisSIDER
702Kidney Diseases26930506CTD
703Metastatic melanomaSIDER
704Neoplasm Invasiveness26640592CTD
705melanoma

View details

CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.